103 related articles for article (PubMed ID: 9557399)
1. Intracellular transport of molecules engaged in the presentation of exogenous antigens.
Nordeng TW; Gorvel JP; Bakke O
Curr Top Microbiol Immunol; 1998; 232():179-215. PubMed ID: 9557399
[No Abstract] [Full Text] [Related]
2. The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation.
Nordeng TW; Bakke O
Immunol Lett; 1994 Dec; 43(1-2):47-55. PubMed ID: 7737689
[TBL] [Abstract][Full Text] [Related]
3. Invariant chain, a chain of command.
Matza D; Kerem A; Shachar I
Trends Immunol; 2003 May; 24(5):264-8. PubMed ID: 12738421
[No Abstract] [Full Text] [Related]
4. MHC class II antigen processing: biology of invariant chain.
Sant AJ; Miller J
Curr Opin Immunol; 1994 Feb; 6(1):57-63. PubMed ID: 8172680
[TBL] [Abstract][Full Text] [Related]
5. Business as usual: the p35 isoform of human CD74 retains function in antigen presentation.
Bergmann H
Immunol Cell Biol; 2012 Oct; 90(9):839-40. PubMed ID: 23032370
[No Abstract] [Full Text] [Related]
6. Biologic consequences of defective major histocompatibility complex class II presentation.
Eibl MM; Wolf HM
Curr Top Microbiol Immunol; 1998; 232():217-40. PubMed ID: 9557400
[No Abstract] [Full Text] [Related]
7. [MHC class II restricted antigen presentation].
Hirata S; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
[No Abstract] [Full Text] [Related]
8. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
9. Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.
Barabanova YA; Kang HK; Myoung J; Kang B; Bishop GA; Kim BS
Immunology; 2004 Feb; 111(2):165-72. PubMed ID: 15027901
[TBL] [Abstract][Full Text] [Related]
10. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
11. Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.
Frauwirth K; Shastri N
Immunology; 2001 Apr; 102(4):405-15. PubMed ID: 11328374
[TBL] [Abstract][Full Text] [Related]
12. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
[TBL] [Abstract][Full Text] [Related]
13. CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.
Beswick EJ; Reyes VE
World J Gastroenterol; 2009 Jun; 15(23):2855-61. PubMed ID: 19533806
[TBL] [Abstract][Full Text] [Related]
14. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.
Martin WD; Hicks GG; Mendiratta SK; Leva HI; Ruley HE; Van Kaer L
Cell; 1996 Feb; 84(4):543-50. PubMed ID: 8598041
[TBL] [Abstract][Full Text] [Related]
15. Presentation of antigens by MHC class II molecules: getting the most out of them.
Villadangos JA
Mol Immunol; 2001 Sep; 38(5):329-46. PubMed ID: 11684289
[TBL] [Abstract][Full Text] [Related]
16. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
Engering A; Lefkovits I; Pieters J
Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
[TBL] [Abstract][Full Text] [Related]
17. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
18. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
19. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
Germain RN
Semin Immunol; 1995 Dec; 7(6):361-72. PubMed ID: 8775462
[TBL] [Abstract][Full Text] [Related]
20. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
